Suppr超能文献

葡聚糖衍生物和一种岩藻依聚糖组分的抗凝活性比较及其对凝血酶生成的影响。

Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction.

作者信息

Mauray S, De Raucourt E, Chaubet F, Maïga-Revel O, Sternberg C, Fischer A M

机构信息

Laboratoire d'hématologie, C.H.U. Necker-Enfants Malades, Université Paris V, France.

出版信息

J Biomater Sci Polym Ed. 1998;9(4):373-87. doi: 10.1080/09205063.1998.9753062.

Abstract

CMDBS compounds are synthetic dextran derivatives with a random distribution of glucosyl units substituted with carboxymethyl, benzylamide, sulfonate, and sulfate groups. Fucoidans are sulfated polysaccharides extracted from brown seaweeds. CMDBS and fucoidans exhibit anticoagulant activity which depends on their chemical composition and molecular weight. Tested with purified proteins, these compounds catalyse thrombin (EC 3.4.21.5) inhibition mainly via heparin cofactor II (HCII). We investigated the mechanism involved in the anticoagulant activity of these polysaccharides relative to that of heparin. Three CMDBS with different chemical compositions were studied to evaluate the effect of sulfate and sulfonate groups on the anticoagulant activity. The fucoidan fraction was extracted from the brown seaweed Ascophylum nodosum. The clotting assays (activated partial thromboplastin time, thrombin time, prothrombin time) were significantly prolonged in the presence of CMDBS and fucoidan, which were less active than heparin. To investigate the action mechanism of these polysaccharides, thrombin generation tests (TGT) were performed on human plasma in the presence of several CMDBS and a fucoidan fraction. The results showed an inhibition of thrombin generation in contact-activated plasma in the presence of both polysaccharides, with a prolonged lag phase preceding the burst of thrombin generation. In thromboplastin-activated plasma, thrombin generation was inhibited by CMDBS and fucoidan, with a prolonged lag phase only in the presence of CMDBS. The data obtained with each polysaccharide, compared to those obtained with heparin (our study) and hirudin (published data), led to hypothesize that fucoidan could act, like heparin, by forming complexes with the inhibitor (although antithrombin (AT) in the case of heparin, and HCII for fucoidan), while CMDBS could act, like hirudin, by forming complexes with thrombin.

摘要

CMDBS化合物是具有随机分布的葡糖基单元的合成葡聚糖衍生物,这些葡糖基单元被羧甲基、苄基酰胺、磺酸盐和硫酸盐基团取代。岩藻依聚糖是从褐藻中提取的硫酸化多糖。CMDBS和岩藻依聚糖表现出抗凝活性,其活性取决于它们的化学组成和分子量。用纯化蛋白进行测试时,这些化合物主要通过肝素辅因子II(HCII)催化凝血酶(EC 3.4.21.5)的抑制作用。我们研究了这些多糖相对于肝素的抗凝活性所涉及的机制。研究了三种化学组成不同的CMDBS,以评估硫酸盐和磺酸盐基团对抗凝活性的影响。岩藻依聚糖部分是从褐藻墨角藻中提取的。在CMDBS和岩藻依聚糖存在的情况下,凝血试验(活化部分凝血活酶时间、凝血酶时间、凝血酶原时间)显著延长,其活性低于肝素。为了研究这些多糖的作用机制,在几种CMDBS和一个岩藻依聚糖部分存在的情况下,对人血浆进行了凝血酶生成试验(TGT)。结果表明,在两种多糖存在的情况下,接触激活血浆中的凝血酶生成受到抑制,在凝血酶生成爆发之前有一个延长的延迟期。在组织凝血活酶激活的血浆中,CMDBS和岩藻依聚糖抑制凝血酶生成,仅在CMDBS存在的情况下有一个延长的延迟期。将每种多糖获得的数据与用肝素(我们的研究)和水蛭素(已发表的数据)获得的数据进行比较,结果表明岩藻依聚糖可能像肝素一样,通过与抑制剂形成复合物(肝素的情况是抗凝血酶(AT),岩藻依聚糖是HCII)起作用,而CMDBS可能像水蛭素一样,通过与凝血酶形成复合物起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验